circ_0003633对肺腺癌细胞奥希替尼耐药的作用研究
DOI:
作者:
作者单位:

南京医科大学第二附属医院

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金项目(面上项目,重点项目,重大项目)


Role of circ_0003633 in Osimertinib Resistance in Lung Adenocarcinoma CellsZHANG Ge1, Chen Xin1, GU jingyao1, WANG Zhaoxia1*
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探究circ_0003633在肺腺癌细胞奥希替尼耐药中的作用。方法:通过对奥希替尼耐药细胞和敏感细胞进行circRNA测序,筛选出在耐药细胞中显著高表达的circ_0003633,在奥希替尼耐药细胞中敲低circ_0003633的表达,通过CCK8实验,Transwell实验和平板克隆法研究circ_0003633在肺腺癌奥希替尼耐药细胞中的作用,利用RNA Pull Down、转录组测序及生信分析筛选下游靶基因及信号通路。结果:circ_0003633在奥希替尼耐药细胞中显著高表达,敲低circ_0003633的表达可以显著增加奥希替尼耐药细胞对奥希替尼的敏感性,circ_0003633可以与RNA结合蛋白hnRNPA1结合并调控下游靶基因ALDOC发挥生物学功能。结论:circ_0003633在奥希替尼耐药细胞中显著高表达,与hnRNPA1结合并调控下游靶基因ALDOC,激活PI3K/AKT信号通路,促进肺腺癌细胞对奥希替尼的耐药,可作为逆转耐药的潜在靶点。

    Abstract:

    Objective: To explore the role of circ_0003633 in osimertinib resistance of lung adenocarcinoma cells. Methods: By performing circRNA sequencing on osimertinib-resistant and sensitive cells, circ_0003633 was identified as significantly highly expressed in the resistant cells. The expression of circ_0003633 was knocked down in osimertinib-resistant cells, and its role in osimertinib-resistant lung adenocarcinoma cells was investigated through CCK8 assay, Transwell assay and colony formation assay. RNA Pull Down, transcriptome sequencing and bioinformatics analysis were used to screen downstream target genes and signaling pathways. Results: circ_0003633 is significantly highly expressed in osimertinib-resistant cells. Knockdown of circ_0003633 expression can significantly increase the sensitivity of osimertinib-resistant cells to osimertinib. circ_0003633 can bind to RNA-binding protein hnRNPA1 and regulate the downstream target gene ALDOC to exert biological functions. Conclusion: circ_0003633 is significantly highly expressed in osimertinib-resistant cells, binds to hnRNPA1 and regulates the downstream target gene ALDOC, activates the PI3K/AKT signaling pathway, promotes the resistance of lung adenocarcinoma cells to osimertinib, and can be used as a potential target for reversing drug resistance.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-04-28
  • 最后修改日期:2025-05-19
  • 录用日期:2025-08-25
  • 在线发布日期:
  • 出版日期:
关闭